Viewing Study NCT03311334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-03-04 @ 7:52 PM
Study NCT ID: NCT03311334
Status: TERMINATED
Last Update Posted: 2024-04-18
First Post: 2017-10-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma (RCC) View
None Urothelial Carcinoma View
None Primary Peritoneal Cancer View
None Platinum-resistant Ovarian Cancer (PROC) View
None Serous Epithelial Ovarian Cancer View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DSP-7888 View
None Nelatimotide View
None Adegramotide View
None Opdivo View
None immune checkpoint inhibitor View
None cancer vaccine View
None WT1 View
None ICI View
None Wilms Tumor 1 View
None Ombipepimut-S View
None nivolumab View
None pembrolizumab View
None Keytruda View
None Ovarian cancer View
None Platinum-resistant ovarian cancer View
None PROC View
None Serous epithelial ovarian cancer View
None High-grade serous epithelial ovarian cancer View
None HGSOC View
None Fallopian tube cancer View
None FTC View
None Peritoneal cancer View
None Primary peritoneal cancer View
None PPC View
None Renal cell carcinoma View
None Kidney cancer View
None RCC View
None Metastatic Renal Cell Carcinoma View
None Metastatic RCC View
None Metastatic kidney cancer View
None Advanced Renal Cell Carcinoma View
None Advanced RCC View
None Advanced kidney cancer View
None Urothelial carcinoma View
None Bladder cancer View
None Transitional cell carcinoma View
None UC View
None Metastatic urothelial carcinoma View
None Metastatic transitional cell carcinoma View
None Metastatic UC View
None Advanced urothelial carcinoma View
None Advanced UC View
None Advanced transitional cell carcinoma View